Recombinant Human DYNLL1 (N-6His)

Description

EnkiLife provides the Recombinant Human DYNLL1 (N-6His) protein,aslo know as Dynein Light Chain 1 Cytoplasmic,8 kDa Dynein Light Chain,DLC8,Dynein Light Chain LC8-Type 1,Protein Inhibitor of Neuronal Nitric Oxide Synthase,PIN,DYNLL1;DLC1,DNCL1,DNCLC1,HDLC1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Cytoplasmic Dynein Light Chain 1 is produced by our E.coli expression system and the target gene encoding Met1-Gly89 is expressed with a 6His tag at the N-terminus.Accession:P63167. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:12.5 KDa. Background:Human Dynein Cytoplasmic Light Chain 1 (DYNLL1) has been identified as a protein that interacts with NOS1, leading to NOS1 inhibition. NOS1 dimer is destabilized after binding DYNLL1 a conformation necessary activity, and it regulate numerous biologic processes throughits effects on nitric oxide synthase activity. DYNLL1 is widely expressed, with higher expression in testis and moderate expression in brain.